tiprankstipranks
Data Horizon Co., Ltd. (JP:3628)
:3628
Japanese Market

Data Horizon Co., Ltd. (3628) AI Stock Analysis

0 Followers

Top Page

JP:3628

Data Horizon Co., Ltd.

(3628)

Select Model
Select Model
Select Model
Neutral 49 (OpenAI - 5.2)
Rating:49Neutral
Price Target:
¥508.00
▲(2.63% Upside)
Action:ReiteratedDate:03/24/26
The score is held down primarily by very weak financial performance—large losses, sharply higher leverage, and significant cash burn. Technical indicators are broadly neutral with only mild short-term improvement, while valuation is somewhat supportive due to a low P/E but is not enough to offset the elevated balance-sheet and liquidity risks.
Positive Factors
Revenue Growth Momentum
Sustained ~80% top-line growth indicates strong demand or market traction in the core offering. Over months, persistent revenue expansion can support scale, enable further product investment, and create optionality to improve unit economics and absorb fixed costs, aiding durable recovery.
Negative Factors
Severe Leverage
Debt-to-equity of ~21.7x driven by collapsed equity materially raises refinancing and solvency risk. High leverage constrains strategic flexibility, elevates interest burden and amplifies downside from revenue volatility, making multi-month stability contingent on deleveraging or fresh capital.
Read all positive and negative factors
Positive Factors
Negative Factors
Revenue Growth Momentum
Sustained ~80% top-line growth indicates strong demand or market traction in the core offering. Over months, persistent revenue expansion can support scale, enable further product investment, and create optionality to improve unit economics and absorb fixed costs, aiding durable recovery.
Read all positive factors

Data Horizon Co., Ltd. (3628) vs. iShares MSCI Japan ETF (EWJ)

Data Horizon Co., Ltd. Business Overview & Revenue Model

Company Description
Data Horizon Corporation provides data health support services to insurers in Japan. It develops and provides medical information services, such as health related data and generic drug notification services, as well as a health business support sy...

Data Horizon Co., Ltd. Financial Statement Overview

Summary
Despite ~80% revenue growth, overall financial quality is weak: the company posted a large net loss with negative operating profit, leverage has surged (debt-to-equity ~21.7x due to collapsed equity), and cash flow has flipped to heavy burn (operating and free cash flow around -¥1.9B), increasing liquidity and solvency risk.
Income Statement
18
Very Negative
Balance Sheet
12
Very Negative
Cash Flow
14
Very Negative
BreakdownTTMJun 2024Jun 2023Jun 2022Jun 2021Jun 2020
Income Statement
Total Revenue5.14B5.14B5.01B4.41B2.99B3.33B
Gross Profit1.32B2.07B1.90B1.18B1.44B1.90B
EBITDA82.80M82.80M-148.66M-1.59M-136.32M475.24M
Net Income-3.95B-3.95B-807.18M-664.86M-410.80M283.92M
Balance Sheet
Total Assets7.79B7.79B7.90B7.44B2.26B2.28B
Cash, Cash Equivalents and Short-Term Investments1.22B1.22B1.42B1.08B379.98M1.06B
Total Debt4.81B4.81B2.46B1.47B400.00M2.66M
Total Liabilities7.57B7.57B4.68B3.42B977.21M709.94M
Stockholders Equity221.67M221.67M3.19B3.97B1.26B1.54B
Cash Flow
Free Cash Flow-154.63M-1.89B64.81M-253.54M-747.41M232.91M
Operating Cash Flow-145.58M-1.88B120.13M-198.37M-442.98M395.94M
Investing Cash Flow-177.67M-673.71M-789.14M-3.51B-572.80M-391.51M
Financing Cash Flow410.07M2.35B1.02B4.41B331.20M-56.21M

Data Horizon Co., Ltd. Technical Analysis

Technical Analysis Sentiment
Neutral
Last Price495.00
Price Trends
50DMA
501.86
Positive
100DMA
510.99
Negative
200DMA
539.97
Negative
Market Momentum
MACD
-0.42
Positive
RSI
50.98
Neutral
STOCH
40.00
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:3628, the sentiment is Neutral. The current price of 495 is below the 20-day moving average (MA) of 514.90, below the 50-day MA of 501.86, and below the 200-day MA of 539.97, indicating a neutral trend. The MACD of -0.42 indicates Positive momentum. The RSI at 50.98 is Neutral, neither overbought nor oversold. The STOCH value of 40.00 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for JP:3628.

Data Horizon Co., Ltd. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (51)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
70
Outperform
¥1.12T18.9112.15%1.01%33.50%17.26%
63
Neutral
¥65.67B228.030.39%6.17%-8918.66%
63
Neutral
¥233.94B26.760.43%20.55%48.62%
51
Neutral
$7.86B-0.30-43.30%2.27%22.53%-2.21%
51
Neutral
¥69.14B77.035.76%31.95%-40.95%
49
Neutral
¥6.41B10.51-4.07%-88.89%
44
Neutral
¥2.79B-4.2816.19%-4.42%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
JP:3628
Data Horizon Co., Ltd.
507.00
103.00
25.50%
JP:2413
M3
1,645.00
0.53
0.03%
JP:4480
Medley
2,112.00
-1,013.00
-32.42%
JP:3902
Medical Data Vision Co.Ltd.
1,684.00
1,292.00
329.59%
JP:4438
Welby Inc.
337.00
52.00
18.25%
JP:4483
JMDC Inc.
3,575.00
684.56
23.68%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Mar 24, 2026